Tubiana Lab- Machine Learning for Computational Structural Biology & Protein Design
The Tubiana Lab leverage advanced machine learning and statistical physics to decode complex biological structures and engineer functional proteins. By developing generative AI models and data-driven computational algorithms, the lab accelerates biotherapeutic discovery, enabling the rational design of custom proteins and molecular interactions with high specificity.
Research Focus
- Computational Structural Biology: Applying statistical physics and machine learning to model protein structures, dynamics, and molecular interactions at atomic resolution.
- AI-Driven Protein Design: Developing generative artificial intelligence models to design novel functional proteins, enzymes, and therapeutic scaffolds from scratch.
- Machine Learning for Biomolecules: Building specialized deep learning and statistical inference frameworks to analyze large-scale biological datasets and predict molecular function.
Capabilities
- Generative AI & Machine Learning Modeling: Custom machine learning architectures tailored for biomolecular sequence, structure, and interaction predictions.
- Statistical Physics & Computational Frameworks: Physical-statistical modeling methods to evaluate protein stability, folding landscapes, and conformational changes.
- In-Silico High-Throughput Screening: Computational pipelines for rapid screening and optimization of candidate protein leads prior to experimental synthesis.
Partnership & Opportunities in Different Industries
- Biopharma & Therapeutic Protein Discovery: Partnering with biotechnology and pharmaceutical companies to design novel antibody candidates, peptide drugs, and targeted protein therapeutics.
- Industrial & Synthetic Biology: Collaborating with agtech and industrial biotech partners to engineer custom enzymes and biocatalysts with enhanced stability and activity.
- Software & Computational Bio Tools: Licensing proprietary machine learning algorithms and computational tools to life science software and platform companies.
- Potential Market Segments: ICT & Media (Machine learning & AI), Therapeutics (Drug Discovery, Bioconvergence), Research Tools (Research Software), Synthetic Biology.
Selected Publications
- Generative models and statistical physics approaches for protein sequence and structure modeling – Demonstrating machine learning frameworks for predicting structural conformations and functional mutations.
- Machine learning architectures for de novo protein design – Outlining data-driven computational strategies to design novel, stable protein geometries for biomedical applications.
Contact:
Email: jeromet@tauex.tau.ac.il
Email
Linkedin
WhatsApp
Print/PDF